DCs can be activated by molecular patterns from pathogens or by endogenous danger signals. It was previously shown that preformed Ag-Ab immune complexes (ICs) efficiently activate DCs and greatly enhance the efficacy of Ag presentation in vitro (1-3).
Importantly, this was recently confirmed by in vivo formed ICs using mice with pre-existent circulating Abs, underscoring the physiological relevance of this mechanism (4) .
Interaction of IgG-ICs and FcgRs induces various effector mechanisms depending on the type of FcgR (5) . Mouse DCs express three activating FcgRs (FcgRI, FcgRIII, and FcgRIV) and the inhibitory FcgRIIB. The activating FcgRs associate with the FcRg-chain that initiates signal transduction via the ITAM. ITAM signaling involves the phosphorylation of its tyrosine residues by Src family kinases, which then provides a docking site for the protein tyrosine kinase Syk. Syk activation results in phosphorylation of ERK, influx of extracellular calcium, and ultimately NF-kB activation (6) . The inhibitory FcgRIIB is a single-chain receptor that contains an ITIM in its intracellular tail. The balance between activating versus inhibitory FcgR signaling determines the magnitude of the effector response.
Studies with FcRg-chain knockout (FcRg 2/2 ) mice showed that IC-enhanced Ag presentation by DCs requires activating FcgRs (1, 7) . In contrast, signaling via FcgRIIB inhibits Ag presentation by DCs both in vitro (8) and in vivo (2) . Uptake of ICs by APCs normally results in Ag presentation on MHC class II (MHC II) molecules; however, DCs are equipped to also present these Ags on MHC class I, a process called crosspresentation (9) . The mechanism of FcgR-mediated enhancement of cross-presentation is not fully understood. FcgR-mediated IC uptake is very efficient and results in routing of the Ag into specialized intracellular compartments that allow prolonged Ag presentation (10) . Furthermore, it was shown that interaction between activating FcgR and IC leads to DC maturation (3) and requires components of FcRg-chain ITAM signaling cascade, such as Syk (11) . Syk 2/2 DCs exhibit abrogated IC internalization and DC activation by ICs (11) . This suggests that FcRg-chain signaling is important in Ag presentation; however, Syk deletion also impairs the signaling of other ITAM-dependent receptors, such as integrins (12) . Several studies used FcRg 2/2 mice to demonstrate the importance of FcgR signaling, but these mice do, however, lack surface expression of all activating FcgRs. Therefore, the specific role of FcRg-chain ITAM in Ag presentation could not be studied.
In this study, we investigated the specific requirement for FcRgchain ITAM signaling for FcR-facilitated presentation of ICderived Ag, whereas surface expression of FcgR was normal. To this end, we used DCs derived from previously generated NOTAM mice. These mice express normal levels of activating FcgRs, but, due to a mutation in their FcRg-chain, ITAM are incapable of canonical FcgR signaling (13) .
We show that NOTAM DCs can internalize soluble OVA-IC, albeit less efficient compared with wild-type (WT) DCs. In addition, despite IC internalization and Ag delivery at levels compatible with presentation in the WT cells, Ag presentation on both MHC class I (MHC I) and MHC II in vitro was completely abrogated similar to FcRg 2/2 DCs in line with signal-dependent facilitation of the Ag delivery process for both MHC class I and MHC class II.
Materials and Methods
Mice C57BL/6Jico mice were obtained from Janvier (Le Genest Saint Isle, France). FcRg 2/2 , NOTAM (13), OT-I, and OT-II mice on C57BL/6 background were maintained in the Animal Facility of University Medical Center Utrecht. All experiments were approved by the Animal Ethical Committee of the University Medical Center Utrecht.
Cell culture
A total of 3 3 10 6 bone marrow (BM) cells was seeded in 10-cm plastic petri dishes in 10 ml D1 medium containing IMDM (Biowhitaker) supplemented with 50 mM 2-ME, 200 mM Ultraglutamine I (Biowhitaker), Pen/Strep (Life Technologies), 10% FCS, and 30% conditioned supernatant from GM-CSFproducing NIH 3T3 cells (R1) (14) . On day 3, 10 ml fresh medium was added to the dish. On days 6 and 8, the medium was partially refreshed, and, on day 9, the cells were reseeded in fresh medium at 3 3 10 6 DC/ml. On day 13, semiadherent cells were collected and used for experiments.
B3Z T cells, a C57BL/6-derived mouse hybridoma specific for OVApeptide SIINFEKL in MHC I context (H-2Kb), were cultured in IMDM (Life Technologies, Invitrogen) supplemented with 10% FCS, Pen/Strep, and 500 mg/ml hygromycin B (Invitrogen) (15 To generate BM-derived macrophages (BMDMs), after the lysis of the erythrocytes, 3 3 10 6 BM cells were seeded in a 6-well plate. Cells were cultured in RPMI 1640 (Life Technologies) with 10% heat-inactivated FCS, Pen/Strep, and 10 ng/ml GM-CSF (Immunex, Seattle, WA). Medium was refreshed on days 2 and 5. At day 8, the adherent cells were harvested with 50 mM EDTA.
Bacterial phagocytosis assay
Phagocytosis of opsonized Streptococcus pneumoniae was measured in a FACS-based assay, as described previously (16) . Briefly, opsonization was achieved by a human IgG1 Ab specific for S. pneumoniae, provided by G. Vidarsson (Sanquin, Amsterdam). BM-derived macrophages (2 3 10 5 ) and 5 ml human IgG1-opsonized S. pneumoniae (serotype 6A) were added together in a total volume of 55 ml using a 96-well plate format. Binding was allowed at 4˚C for 1 h, after which the cells were washed once with cold RPMI 1640 medium. Half of the cells were placed at 37˚C for 30 min to allow phagocytosis; the other half was kept cold. Binding of bacteria was determined by FACS using a PE-conjugated anti-human IgG Ab. Phagocytosis was defined as the difference between the signals of antihuman IgG1 Ab at 4˚C and 37˚C.
IC formation
ICs were formed by incubating 100 mg/ml OVA (Worthington) and 400 mg/ml rabbit anti-OVA (Sigma-Aldrich; C6543) in a total volume of 100 ml (RPMI 1640) at 37˚C for 30 min. This was used as stock OVA-IC at a concentration of 100 mg/ml and was diluted further. For confocal microscopy and OVA degradation experiments, we used Alexa594-or Alexa488-labeled OVA, respectively (Molecular Probes; O-34781 and O-34783).
IC binding and internalization
A total of 2 3 10 5 DCs was incubated in a U-bottom 96-well plate with different concentrations of OVA-ICs in a total volume of 100 ml for 4 h on ice to measure binding. To measure uptake, BM-derived DCs (BM-DCs) were first incubated with OVA-ICs for 4 h on ice, followed by 1 h at 37˚C. To discriminate between binding and uptake, extracellular fluorescence was quenched using trypan blue, and samples were measured on FACSCalibur and analyzed using CellQuest software. (15) . Ag presentation efficacy was determined after cell lysis and measuring b-galactosidase activity. As a positive control, we used the SIINFEKL peptide or OVA protein.
Ex vivo Ag presentation
To determine the Ag-presenting capacity after IC uptake of ex vivo sorted DCs, CD11b
high splenocytes from WT, FcRg 2/2 , and NOTAM mice were sorted using FACS AriaII. A total of 10 4 splenic DCs was plated in round-bottom 96-well plates (NUNC) in IMDM supplemented with 10% and Pen/Strep. For MHC II Ag presentation, 1 mg/ml OVA 323-329 peptide, 100 mg/ml OVA, or 0.2 mg/ml OVA-IC was added. For cross-presentation, 1 ng/ml SIINFEKL, 250 mg/ml OVA, and 0.02 mg/ml OVA-IC were added. OVA-specific CD4-and CD8-positive T cells were isolated from the spleens of OT-I and OT-II mice using a CD4 or CD8 T cell isolation kit, according to manufacturer's instructions (Miltenyi Biotec). OT-I spleen contained ∼97% CD8 + cells within the CD3 + fraction, which was enriched to 99.6% after MACS sorting. OT-II spleen contained ∼50% CD4 + cells within the CD3 + fraction, and this was enriched to ∼73% after MACS sorting. T cells were labeled with 0.5 mM CellTrace violet (Life Technologies), according to manufacturer's instructions. A total of 5 3 10 4 T cells was added per well (DC:T ratio of 1:5) and incubated for 4 d. Cells were harvested and labeled with CD3-, CD4-, and CD8-specific Abs, respectively. The dilution of the dye as measure of proliferation specifically in either the CD4 + or CD8 + populations was measured by FACSCantoII and analyzed using FACSdiva software.
IL-2 ELISA
Maxisorp plates (NUNC) were coated with 2 mg/ml anti-IL-2 Ab (BD Pharmingen; 554424) overnight at 4˚C, blocked with 1% BSA, and incubated with supernatants for 2 h at room temperature. Bound IL-2 was detected using 2 mg/ml biotin-conjugated anti-IL-2 Ab (BD Pharmingen; 554426), in combination with streptavidin-HRP and ABTS substrate.
Antibodies
Before the staining for flow cytometry, DCs were blocked with 5% heatinactivated normal mouse serum for 1 h at room temperature. The following Abs and conjugates were used in this study: CD11b 
Assessment of cytokine production after stimulation by ICs
Supernatants were harvested at 48 h after stimulation with ICs or with culture medium. Cytokine production was assessed using a Luminex mouse 23-plex cytokine panel on Bioplex suspension array system (Bio-Rad). Data were analyzed using Bioplex Manager software.
Confocal microscopy
Suspended DCs at 10 6 cells/ml medium were incubated in the presence or absence of 1 mg/ml OVA-IC, as described using Alexa594-conjugated OVA for 4 h at 37˚C, 5% CO 2 , in Eppendorf reaction tubes. The tubes were flicked to prevent attachment at 2 and 4 h. Next, 5 3 10 4 cells were spotted in 24-well plates on Alcian blue-coated coverslips (8 mm; World Precision Instruments) on ice for 45 min. Fixation was done by adding 1 vol 4% paraformaldehyde (EMS) in phosphate buffer (0.1 M, pH 7.4) on ice for 5 min, and, after transfer to room temperature and another 10 vol, fixative was added for 25 min. Fixative was removed by washing with PBS. Simultaneous quenching, blocking, and permeabilization were performed by incubation in PBS containing 0.1% saponin (Riedel de Haen), 2% BSA (purified fraction V; Sigma-Aldrich), and 50 mM NH 4 Cl at room temperature for 20 min. Staining was performed in the same buffer without NH 4 Cl at room temperature for 30 min. Directly conjugated Abs were used, as follows: anti-MHC II-Alexa647 (M5/114.15.2; BioLegend), anti-LAMP1-Alexa488 (1D4B; Santa Cruz Biotechnology), and anti-H2-DM (2E5A; BD Biosciences), which was Alexa488 conjugated (Apex labeling kit; Invitrogen), according to the manufacturer's instructions. After washing three times with buffer, the coverslips were mounted using FluorSave (Calbiochem).
Images were acquired using a Leica SPE-II confocal microscope (Wetzlar, Germany) using standardized settings and a 363 objective lens. Images were imported into ImageJ/FIJI (National Institutes of Health) using the BioLOCI plugin (17) and subsequently background adjusted and color coded.
OVA degradation
To measure intracellular OVA degradation, DCs were incubated with OVAAlexa488 or OVA-Alexa488-IC for the indicated time periods. Thereafter, DCs were extensively washed with PBS to remove serum proteins. The DC pellets were directly dissolved in sample buffer and boiled for 5 min at 95˚C. Cell lysates of 200,000 cells were run on a 15% SDS-PAGE. Gels were scanned on the Typhoon 9410 Variable Mode Imager using 532 nm green laser in combination with emission filter 526 SP (Amersham Biosciences). Gels were quantified using ImageQuant, and OVA degradation was calculated by dividing the signal intensities below the OVA band by all the signals recorded from an individual lane.
Statistical analysis
Parametric data were compared using Student t test. Significance levels were indicated as follows: *p , 0.05, **p , 0.01, and ***p , 0.001. All error bars represent the SD of the mean.
Results
Normal IC binding, but decreased IC uptake by DCs in the absence of FcRg-chain ITAM signaling
To study the role of FcRg-chain ITAM signaling in Ag presentation, we used BM-DC cultured from NOTAM mice. In these mice, the FcRg-chain ITAM motif is mutated, resulting in normal surface expression of activating FcgR, but abrogated effector functions, such as Ab-dependent cell-mediated cytotoxicity or secretion of reactive oxygen intermediates (13) . WT and FcRgchain knockout (FcRg 2/2 ) were used as controls. Flow cytometric analysis before the experiments showed that typically ∼90% of the cultured untreated cells were CD11c positive and immature as only ∼10% of the cells expressed CD40 and CD86 costimulatory markers (P. Boross, D.A.C. Stapels, C. Bertens, and J.H.W. Leusen, unpublished observations). NOTAM DCs expressed similar levels of activating FcgR to WT BM-DCs in line with earlier findings on other cell types (13) . The expression of the inhibitory FcgRIIB was similar in all three strains (Fig. 1A) .
Previously, we found that phagocytosis of opsonized tumor cells (13) or erythrocytes (P. Boross, D.A.C. Stapels, C.E.v.d. Poel, C. Bertens, and J.H.W. Leusen, unpublished observations) was abrogated by NOTAM macrophages. To study phagocytosis of smaller particulate ICs, we used opsonized S. pneumoniae. NOTAM BMDMs were able to bind opsonized S. pneumoniae similar to WT BMDMs (Supplemental Fig. 1A) . WT BMDMs were able to phagocytose opsonized S. pneumoniae, whereas phagocytosis of opsonized bacteria was fully abrogated by NOTAM BMDMs (Supplemental Fig. 1B) . These findings are in line with published data and confirm that FcRg-chain ITAM signaling is absolutely required for phagocytosis of particulate Ags (18) .
To study smaller, soluble Ags, we used ICs of OVA and rabbit anti-OVA (OVA-IC). The optimal ratio of OVA and anti-OVA was determined beforehand (P. Boross, N.v. Montfoort, D.A.C. Stapels, C. Bertens, and J.H.W. Leusen, unpublished observations). NOTAM BM-DCs bound OVA-IC with comparable efficacy to WT BM-DCs in contrast to FcRg 2/2 BM-DCs, where binding was absent (Fig. 1B) ,
indicating that FcgRIIB does not contribute to binding. Although uptake of IC by NOTAM BM-DCs was markedly decreased compared with WT BM-DCs, it was clearly more efficient than in FcRg 2/2 BM-DCs (Fig. 1C) . The kinetic of IC binding by NOTAM BM-DCs was normal, but IC uptake was reduced compared with WT BM-DCs (Supplemental Fig. 2A, 2B ). Depending on the experiment, 10-40 times higher OVA-IC concentration was required to equally load NOTAM BM-DCs. We also observed a similar IC uptake pattern using NOTAM BM-derived polymorphonuclear cells, indicating that this phenomenon was not restricted to DCs (P. Boross, J.H.M. Jansen, and J.H.W. Leusen, unpublished observations).
In conclusion, NOTAM BM-DCs can bind small soluble ICs as efficiently as WT BM-DCs, but the uptake of OVA-IC uptake was substantially decreased compared with WT BM-DCs.
MHC class II and class I Ag presentation by BM-DCs after OVA-IC uptake is fully abrogated in the absence of FcRg-chain ITAM signaling
To investigate the requirement for FcRg-chain ITAM signaling during Ag presentation, we tested the ability of NOTAM BM-DCs to present Ag in the context of MHC II after uptake of OVA-IC. We used T cell clones (BO.97.10.3) that specifically recognize OVA-derived peptides in the context of MHC II, and the efficacy of Ag presentation was measured by the secretion of IL-2 to the supernatant. Ag presentation of the OVA 323-339 peptide and soluble OVA was equally efficient in the three types of BM-DCs ( Fig. 2A, 2B ). However, MHC II presentation of OVA-IC was absent in NOTAM and FcRg 2/2 BM-DCs even at high OVA-IC concentrations (Fig. 2C) . It is known that, next to MHC II presentation, uptake of ICs by FcgR leads to efficient cross-presentation to CD8 + cytotoxic T lymphocytes in the context of MHC I (1). Therefore, we next assessed MHC I-mediated presentation by BM-DCs after IC uptake. All three genotypes of BM-DCs were equally potent in T cell activation when the immunodominant peptide (SIINFEKL) (Fig. 3A) or high concentrations of free OVA were used (Fig. 3B) , the uptake of which is FcgR independent, but rather mannose receptor dependent (19) . This indicates that BM-DCs of all genotypes were capable to cross-present. Thousand-fold lower amounts of ICs induced Ag presentation by WT BM-DCs, but not by FcRg 2/2 or NOTAM BM-DCs (Fig. 3C) .
To further establish the essential role of FcgR in Ag presentation, OVA-ICs were disrupted by sonication and tested for their ability to induce Ag presentation. Indeed, Ag presentation was severely diminished upon sonication, further confirming the requirement for intact ICs and excluding the argument that released OVA would be sufficient for Ag delivery (Supplemental Fig. 3) .
Together, these data show that FcRg-chain ITAM signaling is essentially required for both MHC II and MHC I presentation of internalized Ags.
Lack of DC activation in the absence of FcRg-chain ITAM stimulus
FcgRs are required for IC-induced DC maturation (1, 8) . Therefore, we assessed DC activation after stimulation with ICs or LPS for 48 h. After IC stimulation, the activation markers CD40 and CD86 were upregulated in WT BM-DCs, but not in NOTAM BMDCs. However, NOTAM BM-DCs responded similarly to activation by the TLR ligand LPS (Fig. 4A) .
WT BM-DCs secrete various cytokines and chemokines after FcgR stimulation, which is greatly diminished in FcRg 2/2 BMDCs (8) . WT BM-DCs secreted MIP-1a, IL-6, and IL-2 after 48-h stimulation with ICs, which was completely abrogated by FcRg
BM-DCs in line with earlier findings (Fig. 4B) . Secretion of these cytokines was also fully abrogated by NOTAM BM-DCs (Fig. 4B) . Taken together, these data suggest that DC activation is abrogated in NOTAM BM-DCs.
Abrogated endosomal routing of ICs in NOTAM BM-DCs after FcgR-mediated uptake
After FcgR targeting on BM-DCs, OVA-ICs are transported to late endosomes, as identified by the presence of LAMP-1 (10, (20) (21) (22) . The intracellular localization of the Ag is crucial for entering the Ag presentation pathway (9). We performed confocal microscopy studies to examine the role of FcRg-chain ITAM signaling in intracellular trafficking of OVA. We generated ICs using Alexa594-labeled OVA and determined its localization in all three genotypes of BM-DCs after 4 h of uptake.
In WT BM-DCs, OVA was localized intracellularly and colocalized with LAMP-1-positive late endosomes (Fig. 5) and HLA-DM-positive endosomes (Supplemental Fig. 4) . MHC II was transferred to the membrane typical of activated DCs. FcRg These results confirm that uptake of OVA-IC is greatly reduced in NOTAM BM-DCs. In addition, the results suggest that the internalized OVA-IC is routed toward different compartments in NOTAM DCs compared with WT DCs. These data suggest that the trafficking of OVA-IC to late endosomes after FcgR-mediated uptake is dependent on FcRg-chain ITAM signaling.
Abrogated Ag degradation in the absence of FcRg-chain ITAM signaling
In contrast to macrophages, DCs degrade Ag in a regulated manner, which enables efficient presentation of antigenic peptides even days after Ag uptake in the secondary lymphoid organs (23) . It was demonstrated that OVA-IC internalized by activating FcgRs is routed to specialized intracellular locations in DCs (Ag depots), and OVA remains incompletely degraded for a few days (10) .
In line with this, we observed that OVA-ICs were bound efficiently and partially degraded within hours by WT BM-DCs indicated by the appearance of a dominant cleavage product (indicated by lower arrow) (Fig. 6A) . FcRg 2/2 BM-DCs exhibited decreased binding at 4˚C, confirming the results obtained by flow cytometry (Fig. 6A, middle panel) . Only limited OVA degradation was observed after overnight incubation. NOTAM BM-DCs were able to bind OVA-ICs at 4˚C similar to WT BM-DCs; however, OVA degradation was comparable to FcRg 2/2 BM-DCs (Fig. 6A [right panel], 6B). These results together with those showing internalization of OVAICs by NOTAM BM-DCs suggest that FcRg-chain ITAM signaling is required for OVA degradation after FcgR-mediated uptake.
Ag presentation by splenic DCs
To verify the results obtained with BM-DCs, we also performed Ag presentation experiments with ex vivo sorted splenic DCs from WT, FcRg 2/2 , and NOTAM mice. Splenic DCs were incubated with OVA-IC (and peptide and OVA as control) and freshly isolated OT-I and OT-II T cells labeled with CellTrace violet. After 4 d, proliferation of T cells was assessed by cytofluorimetry using CellTrace violet dilution. MHC II Ag presentation of the OVA 323-339 peptide or high concentrations of free OVA was equally efficient in all three strains (Fig. 7A) . In contrast to WT DCs, MHC II Ag presentation of OVA-IC was absent in FcRg 2/2 DCs. Surprisingly, NOTAM DCs were able to induce proliferation of CD4 + OT-II T cells, suggesting that FcRg-chain ITAM signaling is not essentially required for MHC II Ag presentation (Fig. 7) . were incubated for 48 h with 1 mg/ml ICs. Supernatants were collected after 48 h to assess cytokine secretion. The levels of indicated cytokines were measured by Luminex bead array.
All three types of DCs induced equal proliferation of CD8 + OT-I T cells when incubated with SIINFEKL peptide of OVA (Fig. 8) . However, presentation of OVA-IC was abrogated by both FcRg DCs. However, Ag presentation by NOTAM BM-DCs was fully abrogated even at high IC concentrations, indicating that FcRgchain ITAM signals are specifically required for DC activation and maturation.
In line with data obtained with BM-DCs, cross-presentation of OVA-IC-derived Ags to CD8 + OT-I T cells by NOTAM splenic DCs was fully abrogated. This confirms that the activation of the cross-presentation pathway after OVA-IC uptake can only happen by intact FcRg-chain ITAM signaling. However, in contrast to NOTAM BM-DCs, NOTAM splenic DCs induced proliferation of CD4 + OT-II T cells after OVA-IC uptake. This discrepancy can be best explained by the experimental setup, as follows: BM-DCs were incubated with OVA-ICs for 4 h, after which excess OVA-IC was washed away. In the experiments with ex vivo DCs, OVA-IC was constantly present for 4 d. OVA-IC uptake by NOTAM BM-DCs after 1 h (Fig. 1C ) was decreased compared with WT BM-DCs, and it was even more apparent in other experiments (Fig. 6A ). This suggests that in situations when OVA-IC is present for prolonged periods, uptake of OVA-IC via activating FcgRs (most likely via receptor recycling) can lead to MHC II Ag presentation even in the absence of intact FcRg-chain ITAM signaling. In contrast, cross-presentation of OVA-IC even after prolonged incubation of OVA-IC did not lead to efficient presentation by FcRg
and NOTAM splenic DCs.
Despite the uptake of OVA-ICs by NOTAM BM-DCs, they were not activated, which could account for the defective Ag presentation. TLR triggering can enhance Ag presentation in vitro (24) . Therefore, we attempted to restore Ag presentation by NOTAM BM-DCs through providing an extra activation stimulus through incubation with TLR ligands (LPS or CpG) during Ag presentation. Although TLR triggering induced DC activation, it was not able to restore Ag presentation by NOTAM BM-DCs (P. Boross, D.A.C. Stapels, C. Bertens, and J.H.W. Leusen, unpublished observations). TLR ligand can enhance Ag presentation when directly coupled to the Ag (25). Therefore, it is possible that the Ag and the activating signaling (in this case FcRg-chain ITAM signaling) would have to be in the same intracellular compartment for efficient Ag presentation to induce localized signals.
The defective Ag presentation can be explained by the fact that the IC containing Ag does not reach the lysosomal compartments and the Ag remains stable and is not partially degraded (Figs. 5, 6 ). Interesting to note is that we have also previously shown that DC maturation signals including by FcgR activation lead to functional upregulation of the PA28 proteasome activator complex involved in enhancing MHC class I processing (26) .
It is unclear how IC is internalized by NOTAM BM-DCs. OVA-IC bound on the cell surface of DCs could be internalized in a nonspecific manner due to the active pinocytosis or via the turnover of FcgRs. In contrast to uptake via intact FcgRs, this alternative IC internalization is less efficient and results in altered trafficking and abrogated Ag degradation. Therefore, IC uptake and DC activation are principally regulated by FcRg-chain ITAM signaling.
DCs also express the inhibitory IgG Fc receptor FcgRIIB, which can act as an efficient endocytic receptor for soluble OVA-ICs (27) . Because no IC uptake was observed in FcRg 2/2 BM-DCs expressing normal levels of FcgRIIB, it is unlikely that FcgRIIB contributed to IC internalization in our experiments. Dominant expression of FcgRIIB has a detrimental effect on Ag presentation (28, 29) , and it is a major regulator of DC activity by controlling the expression of a wide range of genes after IC stimulation (8) .
In this study, we did not specifically assess which activating FcgR is important in this effect. Earlier studies using knockout mice demonstrated that deletion of either FcgRI or FcgRIII does not diminish IC-enhanced Ag presentation, indicating that the remaining two activating receptors are sufficient. Deletion of both FcgRI and FcgRIII resulted in abrogated Ag presentation, suggesting a limited role for FcgRIV in this model (1) .
Previous studies by us and others using transfectant cell lines showed that expression of the a-chain of human FcgRI is sufficient for IC internalization, IL-6 production, and MHC II presentation, suggesting that FcRg-chain ITAM signaling is not absolutely required for Ag presentation (30) . These studies, however, used a mouse cell line in combination with ectopic overexpression of the high-affinity human FcgRI, and therefore were less representative of the physiological situation. Furthermore, the intracellular part of mouse FcgRI is different from human FcgRI, which is responsible for the interactions with intracellular proteins that can influence receptor function (31) .
These findings could be important in the context of Ab therapy, in which ICs are formed when dying tumor cells or cell fragments are opsonized with mAb. DCs efficiently take up opsonized Ags (32) . Preclinical evidence shows that tumor destruction by mAbs can lead to Ag presentation and the induction of long-lasting tumor-specific T cell responses (32) . Circulating ICs are primarily cleared by FcgR-expressing macrophages that rapidly degrade Ags, and only a small fraction ends up in DCs (4). Alternative approaches that would enhance DC targeting by mAbs may improve the generation of T cell responses. For instance, glyco-engineered (e.g., fucosenegative) mAbs may enhance Ab-dependent cellular cytotoxicity by altering the activating/inhibitory ratio of FcgRs. At the same time, sugar moieties may engage pattern recognition receptors on DCs and thereby alter signal transduction (33) .
Better insight into how ICs form during Ab therapy and interaction with DC promises to develop novel strategies to generate antitumor immunity. Enhancing FcRg-chain ITAM signaling in DCs may be important to achieve this goal.
